A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
NCT07783425
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
1375
Enrollment
INDUSTRY
Sponsor class
Conditions
Atopic Dermatitis
Interventions
DRUG:
Tilrekimig
DRUG:
Dupilumab
OTHER:
Placebo for Tilrekimig
OTHER:
Placebo for Dupilumab
Sponsor
Pfizer